FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to peptide analogues α-MSH and γ-MSH, which can be used in medicine. Peptide analogs contain the amino acid sequence of human α-MSH or γ-MSH, or variants thereof, and having a branched amino acid probe in the N-terminal part of the peptide are used in pharmaceutical compositions for binding and activating melanocortin receptors MC1r and/or MC3r.
EFFECT: invention allows the effective treatment of an ischemic and/or inflammatory condition.
20 cl, 7 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ALPHA-MELANOTROPIN PEPTIDE ANALOGUES | 2009 |
|
RU2496786C2 |
| ANTIBODIES TARGETING BONE | 2018 |
|
RU2801206C2 |
| PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
| DIRECTED REGENERATION OF BROKEN BONE BY MEANS OF STIMULATION OF PARATHYROID HORMONE RECEPTOR | 2017 |
|
RU2785401C2 |
| MODIFIED ANALOGUES OF GIP PEPTIDE | 2019 |
|
RU2817673C2 |
| PEPTIDE COMPOSITIONS | 2014 |
|
RU2725150C2 |
| ADAM9-BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2783619C2 |
| NOVEL ISOFORM OF TRYPSIN AND USE THEREOF | 2016 |
|
RU2814729C2 |
| PEPTIDIC INTERLEUKIN-23 RECEPTOR INHIBITORS FOR ORAL ADMINISTRATION AND USE THEREOF FOR TREATING INFLAMMATORY INTESTINAL DISEASES | 2015 |
|
RU2736637C2 |
| STRUCTURES HAVING SIRP-ALPHA DOMAIN OR ITS VERSION | 2016 |
|
RU2740672C2 |
